SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
79.95    1.45 (1.85%)
Bid:
79.45
Ask:
79.60
Spread: 0.15 (0.189%)
Market Cap: £1.53b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

27 Mar 2020 07:00

RNS Number : 7885H
Coats Group PLC
27 March 2020
 

27 March 2020

Coats Group plc

Update on trading and impact of Covid-19

Coats Group plc ('Coats,' the 'Company' or the 'Group'), the world's leading industrial thread manufacturer, today provides an update on trading and the impact of Covid-19.

 

In the light of the recent escalation in the Covid-19 outbreak we are particularly focused on 3 priorities in the immediate future. These are 1) continuing to ensure the health and safety of our employees, 2) cash management, and 3) supporting our customers and maintaining the critical elements of our supply chain.

Current trading and outlook

Sales in the first two months of 2020, aside from the previously stated $8 million adverse impact on our China business as a result of Covid-19, were broadly in line with expectations. Since reporting our Full Year 2019 Results on 5 March we have seen the global situation escalate within and beyond the industries in which we operate. This has begun to impact our global demand in March, as brands and manufacturers started to cancel or defer orders, for example due to large scale store closures. In addition, as at 26 March, due to enforced government closures, 15 of our around 50 manufacturing sites are currently subject to temporary shutdown. Indications from those governments are that these sites will return to production in the coming weeks, however we cannot rule out further enforced government closures in these and other geographies.

As a result of this, our Q1 2020 organic revenues will be around 8% down on Q1 2019, with an accelerating organic decline in March, which is expected to be around 15% down year-on-year. Due to current uncertainty over the level of demand reduction across the Group, we are not able at this stage to make accurate forecasts over Full Year 2020 revenues.

Balance Sheet strength

We entered 2020 with a robust Balance Sheet and generating significant levels of cash, which place us in a strong position to manage through this period.

Our committed debt facilities total $575 million across our Banking and US Private Placement group, with a range of maturities from late 2022 through to 2027, and at the end of 2019 we had $290 million of headroom available.

At the end of February, this headroom was $230 million, which is reduced from December 2019 due to the payment of $37 million for the Pharr High Performance Yarns acquisition in February, and normal working capital outflows in Q1. Our debt covenants are two-fold: leverage of no more than 3x EBITDA (0.65x at December 2019) and interest cover of no less than 4x (12.9x at December 2019), which both exclude the impacts of IFRS 16.

Whilst the outlook remains uncertain, we have performed scenario testing, including a significant decline in sales in Q2 and Q3, with a gradual improvement in Q4, which equates to a 30% organic sales decline for the Full Year. In this scenario we still project to operate within our existing facility headroom and covenants.

Management actions

Despite the uncertain environment, we remain confident in our ability to navigate our way through these difficult times. We are taking all necessary actions internally to manage our cost base and cash resources prudently.

These extensive actions include, but are not limited to, significantly reducing our 2020 capital expenditure by c.$30 million from $45-55 million to $15-25 million, temporarily flexing our manufacturing footprint, and reviewing all non-essential discretionary spend. In addition, the Board and Group Executive Team will take a 20% reduction in their salary and fees in Q2. We are also exploring all available government support schemes being put in place around the world, in relation to Covid-19. On cash actions, we are focused on managing our working capital, including heightened credit risk.

Finally, the Board has decided to cancel the proposed 2019 final dividend which was due to be approved at our forthcoming AGM in May. The Board will keep the 2020 interim dividend under review.

Conclusion

Despite these uncertain times, the Board remains confident in the Group's ability to successfully manage through this difficult period and our actions are the prudent ones to take at this time. We enter this phase of our 250+ year history in robust shape and as a market leader with an unrivalled global footprint. Alongside our enhanced operational agility this leaves us well placed to benefit from an acceleration in demand when the virus situation is resolved.

 

Our next scheduled update to the market will be our January-April 2020 trading update on 20 May 2020, prior to our 2020 Annual General Meeting. We will update the market sooner, if required, as events evolve.

 

 

 

 

Enquiry details

Investors

Rob Mann

Coats Group plc

+44 (0)20 8210 5175

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

_________________________________________________________________________________________

 

 

This announcement contains inside information for the purposes of the Market Abuse Regulation.

 

 

About Coats Group plc

Coats is the world's leading industrial thread company. At home in some 50 countries, Coats has a workforce of 17,000 people across six continents. Revenues in 2019 were US$1.4bn. Coats' pioneering history and innovative culture ensure the company continues leading the way around the world. It provides complementary and value added products, services and software solutions to the apparel and footwear industries. It applies innovative techniques to develop high technology Performance Materials threads, yarns and fabrics in areas such as Transportation, Telecommunications and Energy, and Personal Protection. Headquartered in the UK, Coats is a FTSE 250 company, a constituent of the FTSE4Good Index Series and a participant in the UN Global Compact. To find out more about Coats visit www.coats.com.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKABNFBKDDNB
Date   Source Headline
4th Mar 20217:00 amRNS2020 Full Year Results
3rd Mar 20217:00 amRNSRemuneration and Audit Committee Changes
26th Feb 202110:52 amRNSTotal Voting Rights
2nd Feb 202111:30 amRNSHolding(s) in Company
28th Jan 202111:07 amRNSHolding(s) in Company
31st Dec 20201:31 pmRNSTotal Voting Rights
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
1st Dec 20204:05 pmRNSDirector/PDMR Shareholding
26th Nov 202011:11 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSNew Chairman appointment
23rd Nov 20202:29 pmRNSHolding(s) in Company
5th Nov 202012:36 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Statement
14th Oct 20207:00 amRNSConfirmation of CFO Designate start date
6th Oct 202011:09 amRNSBlock listing Interim Review
22nd Sep 20207:00 amRNSDirector Declaration
13th Aug 20207:00 amRNSHalf-year Report
29th Jul 20207:00 amRNSAppointment of Chief Financial Officer Designate
29th Jun 20209:25 amRNSHolding(s) in Company
11th Jun 20203:17 pmRNSResult of AGM
27th May 20204:47 pmRNSDirector/PDMR Shareholding
20th May 20207:00 amRNSTrading Statement
18th May 20202:28 pmRNSNotice of AGM
18th May 202010:03 amRNSDirectorate Change
13th May 20203:06 pmRNSNotice of AGM
28th Apr 20205:24 pmRNSHolding(s) in Company
28th Apr 20201:21 pmRNSNotice of AGM
27th Apr 20202:01 pmRNSDisclosure of rights attached to securities
23rd Apr 20201:48 pmRNSHolding(s) in Company
3rd Apr 20202:13 pmRNSBlock listing Interim Review
2nd Apr 20204:30 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSDirectorate Change
27th Mar 20207:00 amRNSTrading Statement
24th Mar 20204:19 pmRNSHolding(s) in Company
23rd Mar 20209:48 amRNSHolding(s) in Company
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20202:52 pmRNSDirector/PDMR Shareholding
12th Mar 202010:46 amRNSDirector/PDMR Shareholding
11th Mar 202010:14 amRNSHolding(s) in Company
10th Mar 20201:31 pmRNSAnnual Financial Report
9th Mar 20208:13 amRNSDirector/PDMR Shareholding
6th Mar 20202:18 pmRNSDirector/PDMR Shareholding
6th Mar 20202:17 pmRNSDirector/PDMR Shareholding
6th Mar 20208:23 amRNSHolding(s) in Company
5th Mar 20207:00 amRNSFinal Results
2nd Mar 202011:03 amRNSAdditional Listing
28th Feb 20203:48 pmRNSTotal Voting Rights
14th Feb 20201:29 pmRNSHolding(s) in Company
11th Feb 20207:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.